You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 10,342,875


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,342,875 protect, and when does it expire?

Patent 10,342,875 protects JUBLIA and is included in one NDA.

This patent has nineteen patent family members in twelve countries.

Summary for Patent: 10,342,875
Title:Stabilized efinaconazole compositions
Abstract: The present invention provides compositions containing efinaconazole, butylated hydroxytoluene, a salt of ethylenediaminetetraacetic acid, and optional citric acid. The compositions exhibit stable color profiles and are useful in the treatment of fungal infections.
Inventor(s): Bhatt; Varsha (San Francisco, CA), Desai; Nayan (Santa Rosa, CA), Pillai; Radhakrishnan (Santa Rosa, CA)
Assignee: Dow Pharmaceutical Sciences, Inc. (Petaluma, CA)
Application Number:15/607,594
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 10,342,875
Patent Claim Types:
see list of patent claims
Use; Composition; Formulation;
Patent landscape, scope, and claims:

United States Patent 10,342,875: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

Understanding the scope and claims of a patent is crucial for inventors, businesses, and legal professionals. This article provides a comprehensive analysis of United States Patent 10,342,875, including its claims, the patent landscape, and relevant tools and resources for further investigation.

Patent Overview

Patent Number and Title

United States Patent 10,342,875, hereafter referred to as the '875 patent, is a specific patent that has been the subject of legal actions and intellectual property discussions[2][5].

Inventors and Assignees

The '875 patent is held by specific inventors and assigned to companies such as Bausch Americas and Kaken, which are involved in pharmaceutical and related industries. The assignees play a significant role in the patent's enforcement and commercialization[2][5].

Claims Analysis

Claim Structure

Patent claims define the scope of the invention and are critical for determining infringement. The '875 patent includes multiple claims, each detailing a specific aspect of the invention. These claims can be categorized into independent and dependent claims, with the latter building upon the former to provide a more detailed description of the invention[3].

Claim Types

  • Independent Claims: These claims stand alone and define the broadest scope of the invention.
  • Dependent Claims: These claims are narrower and depend on one or more of the independent claims, often adding additional limitations or features.

Claim Scope

The scope of the claims in the '875 patent would typically be analyzed using tools like the Patent Claims Research Dataset provided by the USPTO. This dataset includes detailed information on claims from US patents, allowing for a thorough examination of claim-level statistics and document-level statistics[3].

Patent Landscape

Related Patents and Applications

The '875 patent is part of a larger patent family that includes other related patents and applications. Tools like the Global Dossier and the Common Citation Document (CCD) can help identify these related applications and provide a comprehensive view of the patent family across different intellectual property offices[1].

Citation Data

The CCD application consolidates prior art cited by all participating offices for the family members of a patent application, enabling a single-page view of search results from multiple offices. This is particularly useful for understanding the broader patent landscape and potential prior art that could affect the validity or scope of the '875 patent[1].

Legal and Litigation Context

Infringement Actions

The '875 patent has been involved in several infringement actions, as seen in the legal documents related to Bausch Americas and Kaken versus various defendants. These actions highlight the importance of the patent in the pharmaceutical industry and the efforts of the patent holders to protect their intellectual property[2][5].

Jurisdiction and Venue

The litigation involving the '875 patent often involves complex jurisdictional and venue issues, as seen in the case filings in different judicial districts. Understanding these legal aspects is crucial for navigating the patent's enforcement and potential challenges[5].

Tools and Resources for Analysis

USPTO Public Search Facility

The USPTO Public Search Facility and Patent and Trademark Resource Centers (PTRCs) provide access to patent and trademark information, including tools for searching and analyzing patent claims and scope[1].

Patent Claims Research Dataset

This dataset, provided by the USPTO, contains detailed information on claims from US patents granted between 1976 and 2014 and US patent applications published between 2001 and 2014. It is invaluable for analyzing claim scope and trends[3].

PatentsView Database

The PatentsView database offers bulk downloadable data sets that include detailed information on patent applications, granted patents, and various statistical analyses. This database can be used to contextualize the '875 patent within the broader patent landscape[4].

Statistical Insights

Claim-Level Statistics

Using datasets like the Patent Claims Research Dataset, one can analyze claim-level statistics such as the number of claims, claim dependency, and the scope of the claims. These statistics provide insights into the complexity and breadth of the '875 patent[3].

Document-Level Statistics

Document-level statistics include information on the patent's classification, citations, and other relevant data. These statistics help in understanding the patent's position within the broader intellectual property landscape[3].

Practical Applications

Patent Enforcement

Understanding the scope and claims of the '875 patent is essential for enforcing the patent rights. This involves identifying potential infringers and taking legal action to protect the intellectual property[2][5].

Licensing and Commercialization

The detailed analysis of the patent's scope and claims is also crucial for licensing and commercialization strategies. It helps in determining the value of the patent and negotiating licensing agreements[3].

Key Takeaways

  • Comprehensive Claims Analysis: Understanding the independent and dependent claims of the '875 patent is vital for determining its scope and potential infringement.
  • Patent Landscape: Tools like the Global Dossier and CCD help in identifying related patents and applications, providing a broader view of the patent landscape.
  • Legal Context: The '875 patent has been involved in several infringement actions, highlighting its importance and the need for robust legal protection.
  • Statistical Insights: Datasets from the USPTO and PatentsView provide valuable statistical insights into claim scope and document-level statistics.
  • Practical Applications: Detailed analysis is essential for patent enforcement, licensing, and commercialization strategies.

FAQs

Q: How can I find detailed information on the claims of the '875 patent?

A: You can use the Patent Claims Research Dataset provided by the USPTO, which contains detailed information on claims from US patents and applications[3].

Q: What tools are available for analyzing the patent landscape related to the '875 patent?

A: Tools such as the Global Dossier and the Common Citation Document (CCD) are available for analyzing the patent landscape and identifying related applications[1].

Q: Why is the '875 patent involved in legal actions?

A: The '875 patent is involved in legal actions due to its significance in the pharmaceutical industry and the efforts of the patent holders to protect their intellectual property against potential infringers[2][5].

Q: How can I access statistical data related to the '875 patent?

A: You can access statistical data through the PatentsView database and the Patent Claims Research Dataset provided by the USPTO[3][4].

Q: What is the importance of understanding the scope and claims of the '875 patent for businesses?

A: Understanding the scope and claims is crucial for businesses to enforce patent rights, negotiate licensing agreements, and develop commercialization strategies[3].

Sources

  1. USPTO - Search for patents - USPTO
  2. Insight.RPXCorp - Litigation documents
  3. USPTO - Patent Claims Research Dataset
  4. PatentsView - Data Download Tables
  5. Insight.RPXCorp - Litigation documents (additional)

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 10,342,875

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bausch JUBLIA efinaconazole SOLUTION;TOPICAL 203567-001 Jun 6, 2014 AB RX Yes Yes 10,342,875 ⤷  Subscribe Y ANTIMYCOTIC USES, SPECIFICALLY TREATMENT OF ONYCHOMYCOSIS; TOPICAL TREATMENT OF THE TOENAIL(S) DUE TO TRICHOPHYTON RUBRUM AND TRICHOPHYTON MENTAGROPHYTES ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,342,875

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 2014329421 ⤷  Subscribe
Canada 2924748 ⤷  Subscribe
China 105683184 ⤷  Subscribe
China 110433291 ⤷  Subscribe
European Patent Office 3052487 ⤷  Subscribe
Israel 244850 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.